University of Hull logo

Preferred and actual place of death in haematological malignancy

Howell, D. A.; Wang, H. I.; Roman, E.; Smith, A. G.; Patmore, R.; Johnson, M. J.; Garry, A.; Howard, M.

Authors

D. A. Howell

H. I. Wang

E. Roman

A. G. Smith

R. Patmore

A. Garry

M. Howard

Abstract

Objectives Home is considered the preferred place of death for many, but patients with haematological malignancies (leukaemias, lymphomas and myeloma) die in hospital more often than those with other cancers and the reasons for this are not wholly understood. We examined preferred and actual place of death among people with these diseases. Methods The study is embedded within an established population-based cohort of patients with haematological malignancies. All patients diagnosed at two of the largest hospitals in the study area between May 2005 and April 2008 with acute myeloid leukaemia, diffuse large Bcell lymphoma or myeloma, who died before May 2010 were included. Data were obtained from medical records and routine linkage to national death records. Results 323 deceased patients were included. A total of 142 (44%) had discussed their preferred place of death; 45.8% wanted to die at home, 28.2% in hospital, 16.9% in a hospice, 5.6% in a nursing home and 3.5% were undecided; 63.4% of these died in their preferred place. Compared to patients with evidence of a discussion, those without were twice as likely to have died within a month of diagnosis (14.8% vs 29.8%). Overall, 240 patients died in hospital; those without a discussion were significantly more likely to die in hospital than those who had (p≤0.0001). Of those dying in hospital, 90% and 75.8% received haematology clinical input in the 30 and 7 days before death, respectively, and 40.8% died in haematology areas. Conclusions Many patients discussed their preferred place of death, but a substantial proportion did not and hospital deaths were common in this latter group. There is scope to improve practice, particularly among those dying soon after diagnosis. We found evidence that some people opted to die in hospital; the extent to which this compares with other cancers is of interest.

Journal Article Type Article
Publication Date Jun 1, 2017
Journal BMJ supportive and palliative care
Print ISSN 2045-435X
Electronic ISSN 2045-4368
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 7
Issue 2
Pages 150-157
Institution Citation Howell, D. A., Wang, H. I., Roman, E., Smith, A. G., Patmore, R., Johnson, M. J., …Howard, M. (2017). Preferred and actual place of death in haematological malignancy. BMJ supportive & palliative care, 7(2), (150-157). doi:10.1136/bmjspcare-2014-000793. ISSN 2045-435X
DOI https://doi.org/10.1136/bmjspcare-2014-000793
Keywords Medicine (miscellaneous); Oncology(nursing); Medical–Surgical; General Medicine
Publisher URL http://spcare.bmj.com/content/early/2015/07/08/bmjspcare-2014-000793.abstract
Copyright Statement This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Additional Information This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Files

Article.pdf (286 Kb)
PDF

Copyright Statement
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/




You might also like


Downloadable Citations